This activity is approved for 1.50 contact hours.
Section 1: Introduction
About This Course
Section 2: Medications and Mental Illness
Medications for Psychiatric Disorders
Why Do I Need to Know This?
Questions to Ask About Medications
Types of Psychiatric Medications
What if There’s a Mistake?
Medications and Pregnancy
Section 3: Antipsychotic and Mood Stabilizer Medications
Side Effects of Antipsychotics
Serious Side Effects
Section 4: Medications that Treat Depression, Anxiety, and ADHD
Signs of Depression
Makeeda is Worried
Medications Used to Treat ADHD
Section 5: Conclusion
Monique Kahn, Psy.D. received her doctoral degree in Clinical Psychology from Nova Southeastern University in Florida. She completed a pre-doctoral internship at Spokane Mental Health in Washington, which included specialty rotations in behavioral medicine and time-limited psychotherapies. She is licensed as a psychologist in Maine, where she was in private practice for 14 years, providing services to adult clients with varied presenting issues, but with particular emphasis on the treatment of anxiety disorders, the relationship between psychosocial stress and illness, insomnia, and coping with chronic illness. She has taught in the undergraduate psychology program at Husson University in Maine. In addition, she has worked as a content writer and psychology subject matter expert for several major educational publishing firms. She joined Relias as a clinical content writer and subject matter expert in 2016. Disclosure: Monique Kahn, Psy.D. has declared that no conflict of interest, Relevant Financial Relationship or Relevant Non-Financial Relationship exists.Expert Reviewer: John Cahill, MD, PhD
Dr. Cahill has experience in community psychiatry across both the UK and US healthcare systems. He specializes in building Learning Health Systems for early intervention and 'safety net' behavioral health services - towards better-value, person-centered, integrated care for individuals with severe mental illness and co-occurring substance use disorders. After completing medical school in the UK, Dr. Cahill undertook both psychiatry residency and advanced clinical research fellowships at Yale, with a focus on knowledge translation, from the community to the lab, and vice versa, particularly in the study and management of psychotic disorders and their complex interaction with cannabinoids. He is board-certified in Psychiatry and Addiction Medicine. His work is founded on respect for the patient and caregiver experience, addressing the whole person, judicious prescribing practices and embracing a complex adaptive system perspective. His research interests involve using unifying principles and translational approaches to develop novel biomarkers, treatments, technologies, clinical guidelines and resident curricula for the care of psychotic disorders. He is faculty of both Yale School of Medicine and Yale School of Nursing. Disclosure: John Cahill, MD, PhD has declared that no conflict of interest, Relevant Financial Relationship or Relevant Non-Financial Relationship exists.